.In 2010, neuroscientist and previous Eli Lilly research innovator Steve Paul started a firm that he hoped will trigger a revolution in drug exploration built around a training class of substances dubbed neurosteroids that might assist soothe overactive human brain circuits and also ignite drowsy ones for a lengthy listing of psychiatric and nerve ailments.